Modeling and Simulation - PK/PD Archives

Announcement

Phoenix® PK/PD Software now Includes Generative AI pharmacokinetic (PK) Reports

New module transforms tables, figures and listings into draft PK reports saving scientists weeks of…

Certara2026 年 1 月 12 日

Webinar

Efficient creation of Tables, Figures & Listings with Certara’s Phoenix Cloud TFL Studio APAC Webinar

Certara2026 年 1 月 5 日

Blog

Delivering on Deadline: Why Pharmacometrics (PMx) Is the Anchor of Successful Regulatory Submissions

Explore how PMx regulatory submissions, exposure-response modeling, and strategic pharmacometrics planning support successful and timely…

Certara2025 年 12 月 29 日

Webinar

Alternative parameters in NCA using Phoenix WinNonlin

Certara2025 年 12 月 22 日

Conference

MVA Oncology Network

Certara2025 年 12 月 19 日

Announcement

Certara Announces New Release of Integral® Software

Latest version enhances efficiency, compliance, and user experience for PK scientists Radnor, PA. — December…

Danielle Pillsbury2025 年 12 月 16 日

Blog

Using M&S to Evaluate Oncology Drug Dosing

Learn how modeling & simulation improves oncology drug dosing, optimizing safety, efficacy, and personalized treatment…

Certara2025 年 11 月 14 日

Blog

ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

At ACoP 2025, Certara showcased innovation with the launch of Certara IQ™ and Phoenix® Cloud,…

Certara2025 年 11 月 13 日

On-Demand Webinar

Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix®

Watch our on-demand webinar on empiric PK time-course scaling and learn how Certara’s translational experts…

Certara2025 年 11 月 13 日

Publication

Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema

Certara and Ionis analyzed Phase 3 OASIS-HAE data showing flexible, effective donidalorsen dosing can reduce…

Certara2025 年 11 月 12 日

Modeling and Simulation – PK/PD

Phoenix® PK/PD Software now Includes Generative AI pharmacokinetic (PK) Reports

Efficient creation of Tables, Figures & Listings with Certara’s Phoenix Cloud TFL Studio APAC Webinar

Delivering on Deadline: Why Pharmacometrics (PMx) Is the Anchor of Successful Regulatory Submissions

Alternative parameters in NCA using Phoenix WinNonlin

MVA Oncology Network

Certara Announces New Release of Integral® Software

Using M&S to Evaluate Oncology Drug Dosing

ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix®

Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema

订阅时事通讯

快捷链接

解决方案

联系我们